Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies

Toby Freeman, Fran Baum, Connie Musolino, Joanne Flavel, Martin McKee, Chunhuei Chi, Camila Giugliani, Matheus Zuliane Falcão, Wim De Ceukelaire, Philippa Howden-Chapman, Thanh Huong Nguyen, Hani Serag, Sun Kim, Alvarez Dardet Carlos, Hailay Abrha Gesesew, Leslie London, Jennie Popay, Lauren Paremoer, Viroj Tangcharoensathien, T. SundararamanSulakshana Nandi, Eugenio Villar

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)
57 Downloads (Pure)

Abstract

Previous research on commercial determinants of health has primarily focused on their impact on non-communicable diseases. However, they also impact on infectious diseases and on the broader preconditions for health. We describe, through case studies in 16 countries, how commercial determinants of health were visible during the COVID-19 pandemic, and how they may have influenced national responses and health outcomes. We use a comparative qualitative case study design in selected low- middle- and high-income countries that performed differently in COVID-19 health outcomes, and for which we had country experts to lead local analysis. We created a data collection framework and developed detailed case studies, including extensive grey and peer-reviewed literature. Themes were identified and explored using iterative rapid literature reviews. We found evidence of the influence of commercial determinants of health in the spread of COVID-19. This occurred through working conditions that exacerbated spread, including precarious, low-paid employment, use of migrant workers, procurement practices that limited the availability of protective goods and services such as personal protective equipment, and commercial actors lobbying against public health measures. Commercial determinants also influenced health outcomes by influencing vaccine availability and the health system response to COVID-19. Our findings contribute to determining the appropriate role of governments in governing for health, wellbeing, and equity, and regulating and addressing negative commercial determinants of health.

Original languageEnglish
Article number104860
Number of pages11
JournalHealth Policy
Volume134
Early online date23 Jun 2023
DOIs
Publication statusPublished - Aug 2023
Externally publishedYes

Keywords

  • Comparative study
  • COVID-19
  • Health equity
  • Privatisation
  • Social determinants of health

Fingerprint

Dive into the research topics of 'Illustrating the impact of commercial determinants of health on the global COVID-19 pandemic: Thematic analysis of 16 country case studies'. Together they form a unique fingerprint.

Cite this